Dr. Rob Rohatsch, MD, is a Board-Certified Emergency Medicine physician and urgent care executive. He earned his MD from Jefferson Medical College, currently serves on multiple boards and is Solv’s Chief Medical Officer.
Semaglutide is a medication primarily used for the treatment of type 2 diabetes and obesity, functioning as a...
Rybelsus is the only FDA-approved oral semaglutide tablet. It treats type 2 diabetes in adults and contains...
In recent years, semaglutide has gained significant attention as an effective treatment for weight management...
Ozempic is a medication used primarily for the treatment of type 2 diabetes, according to the NLM. They note...
Ozempic can help people lose weight, but it isn’t FDA-approved for weight loss. It’s approved for type 2...
[toc] Weight loss injections — most of which belong to a drug class called GLP-1 receptor agonists — have...
Ozempic is a medication primarily used for managing type 2 diabetes that has garnered attention for its...
Liraglutide is a medication primarily used to manage type 2 diabetes and, in some cases, to assist with weight...
In recent years, weight loss injections have gained popularity as a potential solution for those struggling...
Most people who take Ozempic or another GLP-1 medication will experience some side effects — usually nausea,...
This site uses cookies to provide you with a great user experience. By using Solv, you accept our use of cookies.